1. Medtech Insight
  2. >>Business
  3. >>Deals

Cordis Makes First Big Post-Cardinal Deal: Agrees To Pay $1.1BN For MedAlliance

 
• By Reed Miller

Cordis plans to acquire MedAlliance, the developer of the Selution SLR drug-eluting vascular balloon, for up to $1.135bn. As part of the deal, Cordis will immediately begin to co-promote Selution SLR in every market where it is available.

A Complementary Acquisition
• Source: Shutterstock

Cordis will pay $235m upfront and up to $900m in additional milestone payments to acquire MedAlliance, the privately held Swiss developer of the Selution SLR sirolimus-eluting vascular balloon.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business